Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 50.50% vs 1.70% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 366.84% vs 5.80% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 22.45% vs 50.18% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -48.48% vs 35.32% in Mar 2024
Compare Balance Sheet Results of Jenburkt Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.41
12.71
-8.30
-65.30%
Share Warrants & Outstandings
Total Reserve
167.36
204.92
-37.56
-18.33%
Shareholder's Funds
171.78
217.64
-45.86
-21.07%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.76
-0.76
-100.00%
Secured Loans
0.00
0.76
-0.76
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.38
-2.80
2.42
86.43%
Other Long Term Liabilities
4.50
0.00
4.50
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
2.20
-2.20
-100.00%
Total Non-Current Liabilities
4.12
0.16
3.96
2,475.00%
Current Liabilities
Trade Payables
8.16
41.16
-33.00
-80.17%
Other Current Liabilities
7.08
4.18
2.90
69.38%
Short Term Borrowings
1.98
26.45
-24.47
-92.51%
Short Term Provisions
1.60
0.79
0.81
102.53%
Total Current Liabilities
18.82
72.58
-53.76
-74.07%
Total Liabilities
194.72
290.38
-95.66
-32.94%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
37.67
137.77
-100.10
-72.66%
Less: Accumulated Depreciation
25.15
51.46
-26.31
-51.13%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
12.52
86.31
-73.79
-85.49%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
40.28
0.00
40.28
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
20.56
8.06
12.50
155.09%
Long Term Loans & Advances
5.80
1.24
4.56
367.74%
Other Non Current Assets
56.89
41.25
15.64
37.92%
Total Non-Current Assets
138.19
136.87
1.32
0.96%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.88
62.14
-53.26
-85.71%
Sundry Debtors
20.73
58.62
-37.89
-64.64%
Cash and Bank
24.65
3.58
21.07
588.55%
Other Current Assets
1.48
24.44
-22.96
-93.94%
Short Term Loans and Advances
0.79
4.73
-3.94
-83.30%
Total Current Assets
56.53
153.51
-96.98
-63.18%
Net Current Assets (Including Current Investments)
37.71
80.93
-43.22
-53.40%
Total Current Assets Excluding Current Investments
56.53
153.51
-96.98
-63.18%
Miscellaneous Expenses not written off
0.00
6.62
-6.62
-100.00%
Total Assets
194.72
290.38
-95.66
-32.94%
Contingent Liabilities
16.50
0.00
16.50
0.00%
Total Debt
1.98
27.22
-25.24
-92.73%
Book Value per share (adjusted)
389.23
171.17
218.06
127.39%
Annual - Borrowings
Borrowings 1.98 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 4.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 50.50% vs 1.70% in Mar 2024
Annual - Fixed Assets
Fixed Assets 52.80 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 366.84% vs 5.80% in Mar 2024
Annual - Investments
Investments 20.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 22.45% vs 50.18% in Mar 2024
Annual - Current Assets
Current Assets 56.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -48.48% vs 35.32% in Mar 2024






